Point72 Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Point72 Asset Management’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-400,000	Closed	-$7.46M	–	1739
2022 Q1	$7.46M	Buy	400,000 +160,000	+67%	+$2.88M	0.03%	590
2021 Q4	$5.13M	Sell	240,000 -514,667	-68%	-$10.1M	0.02%	657
2021 Q3	$13.9M	Buy	754,667 +30,912	+4%	+$622K	0.06%	409
2021 Q2	$15.5M	Buy	723,755 +237,055	+49%	+$4.82M	0.07%	345
2021 Q1	$9.39M	Buy	+486,700	New	+$8.58M	0.04%	436

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Point72 Asset Management's OCDX Position: Q2 2022 in Review

Point72 Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 400,000 shares — an estimated $7.46M sold.

Point72 Asset Management first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $15.5M in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Point72 Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Point72 Asset Management sold 400,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $7.46M.
Point72 Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Point72 Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $15.5M in Q2 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Point72 Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.